Management of acute coronary syndromes: an update
Key result
ACS carries up to ~13% six-month mortality, highest in NSTE-ACS.
Why the study?
Acute coronary syndrome encompasses a spectrum of conditions with variable clinical presentations and significant morbidity and mortality, necessitating updated management strategies.
Structured PICO
P
Population
Patients with acute coronary syndromes (ACS), including ST segment elevation myocardial infarction (MI), non-ST segment elevation MI, and unstable angina
Acute coronary syndromes represent a spectrum of conditions with substantial 6-month mortality and rehospitalization risks.
Authors
Discussion
No takes yet. Share an insight, caveat, or question.
Implication
ACS pathophysiology description is hypothesis-generating; leaves open need for updated trials on plaque-targeted interventions.
Cite This Study
Keith A.A. Fox (2004) conducted a review in Acute coronary syndrome. Acute coronary syndrome carries significant six-month mortality, reaching approximately 12% for ST-elevation myocardial infarction, 13% for non-ST-elevation ACS, and 8% for unstable angina.